ChemicalBook > CAS DataBase List > Tofacitinib Impurity 3
Tofacitinib Impurity 3
- Product Name
- Tofacitinib Impurity 3
- CAS No.
- 1206825-36-6
- Chemical Name
- Tofacitinib Impurity 3
- Synonyms
- Tofatinib Impurity 3;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-, rel-
- CBNumber
- CB94842526
- Molecular Formula
- C13H19N5
- Formula Weight
- 245.32
- MOL File
- 1206825-36-6.mol
More
Less
Tofacitinib Impurity 3 Property
- Density
- 1?+-.0.06 g/cm3(Predicted)
- pka
- 13.36±0.50(Predicted)
Tofacitinib Impurity 3 Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Tofacitinib Impurity 3 Suppliers
- Tel
- 020-61855200 13326451905
- 260366801@qq.com
- Country
- China
- ProdList
- 7796
- Advantage
- 58
- Tel
- 2710913286@.com
- 1513643261@qq.com
- Country
- China
- ProdList
- 14246
- Advantage
- 58
- Tel
- 0755-0755-0755-83725350 13380397412
- Fax
- 0755-28094224
- 3001280422@qq.com
- Country
- China
- ProdList
- 10005
- Advantage
- 58
- Tel
- 18576690171 17386083646
- 3001006472@qq.com
- Country
- China
- ProdList
- 11837
- Advantage
- 58
- Tel
- 13217415044 13217415044
- 2851922763@qq.com
- Country
- China
- ProdList
- 7939
- Advantage
- 58
- Tel
- 18627753421 18627756402
- Fax
- QQ:3001051413
- 3001009495@qq.com
- Country
- China
- ProdList
- 19063
- Advantage
- 58
- Tel
- +8617320513646
- mike@molcoo.com
- Country
- China
- ProdList
- 9457
- Advantage
- 58
- Tel
- +8618627948422
- sale@hdimpurity.com
- Country
- China
- ProdList
- 3389
- Advantage
- 58
More
Less
View Lastest Price from Tofacitinib Impurity 3 manufacturers
ShenZhen H&D Pharmaceutical Technology Co., LTD
- Product
- Tofacitinib Impurity 3 1206825-36-6
- Price
- US $0.00-0.00/mg
- Min. Order
- 10mg
- Purity
- 0.98
- Supply Ability
- 10g
- Release date
- 2024-05-20
1206825-36-6, Tofacitinib Impurity 3Related Search:
Tofacitinib Impurity 6
3-Amino-4-methylpyridine
N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate
13-Deoxyepirubicin
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
3-METHOXYCARBONYLAMINO-4-METHYLPYRIDINE
1-[2-(2-methoxyphenoxy)ethylamino]-3-(9-methylcarbazol-4-yl)oxypropan-2-ol:hydrochloride
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
Methyl (4-Methylpiperidin-3-yl)carbaMate
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride